Amlodipine aspartic acid impurity
Based on 1 Customer Validation
Amlodipine aspartic acid impurity (Amlodipine aspartate) is the impurity of Amlodipine aspartic acid. Amlodipine aspartic acid is a calcium channel blocker with antihypertensive and antianginal properties. Amlodipine aspartic acid impurity can control blood pressure. Amlodipine aspartic acid impurity corrects gut dysbiosis and enhances taurine and hypotaurine metabolism. Amlodipine aspartic acid impurity can be studied in research for NAFLD and hypertension.
For research use only. We do not sell to patients.
- Purity: 99.42%
- CAS No.: 400602-35-9
- Formula: C24H29ClN2O9
- Molecular Weight:524.95
-
Storage:
Sealed storage, away from moisture.
Powder -80°C, 2 years , -20°C, 1 year* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
Solvent & Solubility
- Purity & Documentation
- References
-
Help & FAQs
-
Bioactive Compound Library Max
HY-L181
-
Bioactive Compound Library
HY-L001
-
Membrane Transporter/Ion Channel Compound Library
HY-L011
-
Metabolism/Protease Compound Library
HY-L012
-
Neuronal Signaling Compound Library
HY-L013
-
Anti-Cardiovascular Disease Compound Library
HY-L046
-
Neurodegenerative Disease-related Compound Library
HY-L086
-
Drug Metabolite Library
HY-L098
-
Peptide Library
HY-L105
-
Antihypertensive Compound Library
HY-L145
-
Membrane Protein-targeted Compound Library
HY-L149
-
Membrane Receptor-targeted Compound Library
HY-L150
-
Ion Channel Compound Library
HY-L166
-
MCE Bioactive Compound Library
HY-L001V
-
Peptide Compound Library
HY-L105S
-
Non-Alcoholic Fatty Liver Disease (NAFLD) Compound Library
HY-L199
-
High-Throughput Bioactive Compound Library
HY-L205
All Calcium Channel Isoforms
More
Biological Activity
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:8-week-old male C57BL/6J NAFLD and hypertensive mice[1]
-
Dosage:1.4 and 2.8 mg/kg
-
Administration:Intragastric administration (i.g.) once daily for 8 weeks
-
Result:Decreased plasma ALT and AST levels.
Significantly decreased hepatocellular triglyceride level.
Decreased liver injury and hepatic steatosis and improved impaired plasma triglyceride and cholesterol.
Suppressed fatty acid synthesis and fatty acid uptake.
Induced AMP-activated protein kinase activation and downregulated hepatic protein level of active SREBP1c.
Altered the gut micro-environment in mice.
Stimulated the growth of benign bacteria.
Chemical Information
-
CAS No. 400602-35-9
-
Appearance Solid
-
Molecular Weight 524.95
-
Formula C24H29ClN2O9
-
Color Off-white to light yellow
-
Synonyms
Amlodipine aspartate
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Sealed storage, away from moisture
Powder -80°C 2 years -20°C 1 year * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Solvent & Solubility
DMSO : 50 mg/mL (95.25 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Purity & Documentation
-
Data Sheet (273 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
[1]. Sheraz MA, et al. Formulations of Amlodipine: A Review. J Pharm (Cairo). 2016;2016:8961621. [Content Brief]
[2]. Li, Y., et al., (2022). Amlodipine, an anti-hypertensive drug, alleviates non-alcoholic fatty liver disease by modulating gut microbiota. British journal of pharmacology, 179(9), 2054–2077. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.9049 mL | 9.5247 mL | 19.0494 mL | 47.6236 mL |
| 5 mM | 0.3810 mL | 1.9049 mL | 3.8099 mL | 9.5247 mL | |
| 10 mM | 0.1905 mL | 0.9525 mL | 1.9049 mL | 4.7624 mL | |
| 15 mM | 0.1270 mL | 0.6350 mL | 1.2700 mL | 3.1749 mL | |
| 20 mM | 0.0952 mL | 0.4762 mL | 0.9525 mL | 2.3812 mL | |
| 25 mM | 0.0762 mL | 0.3810 mL | 0.7620 mL | 1.9049 mL | |
| 30 mM | 0.0635 mL | 0.3175 mL | 0.6350 mL | 1.5875 mL | |
| 40 mM | 0.0476 mL | 0.2381 mL | 0.4762 mL | 1.1906 mL | |
| 50 mM | 0.0381 mL | 0.1905 mL | 0.3810 mL | 0.9525 mL | |
| 60 mM | 0.0317 mL | 0.1587 mL | 0.3175 mL | 0.7937 mL | |
| 80 mM | 0.0238 mL | 0.1191 mL | 0.2381 mL | 0.5953 mL |
Amlodipine aspartic acid impurity Related Classifications
HY-128696 Related Classifications
Powered by Bioz